Principal Financial Group’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $14.9M | Sell |
|
|||||
|
2025
Q2 | $15.3M | Sell |
|
|||||
|
2025
Q1 | $12.5M | Buy |
|
|||||
|
2024
Q4 | $2.64M | Buy |
|
|||||
|
2024
Q3 | $1.99M | Buy |
|
|||||
|
2024
Q2 | $1.25M | Sell |
|
|||||
|
2024
Q1 | $1.57M | Sell |
|
|||||
|
2023
Q4 | $3.01M | Buy |
|
|||||
|
2023
Q3 | $1.63M | Buy |
|
|||||
|
2023
Q2 | $1.51M | Sell |
|
|||||
|
2023
Q1 | $1.26M | Sell |
|
|||||
|
2022
Q4 | $1.19M | Buy |
|
|||||
|
2022
Q3 | $1.08M | Sell |
|
|||||
|
2022
Q2 | $1.67M | Buy |
|
|||||
|
2022
Q1 | $977K | Buy |
|
|||||
|
2021
Q4 | $921K | Sell |
|
|||||
|
2021
Q3 | $961K | Buy |
|
|||||
|
2021
Q2 | $1.37M | Buy |
|
|||||
|
2021
Q1 | $1.24M | Buy |
|
|||||
|
2020
Q4 | $2.46M | Sell |
|
|||||
|
2020
Q3 | $1.93M | Sell |
|
|||||
|
2020
Q2 | $2.74M | Sell |
|
|||||
|
2020
Q1 | $2.77M | Buy |
|
|||||
|
2019
Q4 | $2.71M | Sell |
|
|||||
|
2019
Q3 | $3.38M | Buy |
|
|||||
|
2019
Q2 | $2.29M | Buy |
|
|||||
|
2019
Q1 | $879K | Buy |
|
|||||
|
2018
Q4 | $502K | Sell |
|
|||||
|
2018
Q3 | $790K | Buy |
|
|||||
|
2018
Q2 | $504K | Sell |
|
|||||
|
2018
Q1 | $777K | Buy |
|
|||||
|
2017
Q4 | $989K | Buy |
|
|||||
|
2017
Q3 | $502K | Sell |
|
|||||
|
2017
Q2 | $469K | Buy |
|
|||||
|
2017
Q1 | $558K | Sell |
|
|||||
|
2016
Q4 | $500K | Sell |
|
|||||
|
2016
Q3 | $638K | Buy |
|
|||||
|
2016
Q2 | $617K | Buy |
|
|||||
|
2016
Q1 | $415K | Buy |
|
|||||
|
2015
Q4 | $489K | Hold |
|
|||||
|
2015
Q3 | $453K | Buy |
|
|||||
|
2015
Q2 | $464K | Sell |
|
|||||
|
2015
Q1 | $377K | Sell |
|
|||||
|
2014
Q4 | $372K | Sell |
|
|||||
|
2014
Q3 | $334K | Hold |
|
|||||
|
2014
Q2 | $305K | Sell |
|
|||||
|
2014
Q1 | $443K | Sell |
|
|||||
|
2013
Q4 | $516K | Hold |
|
|||||
|
2013
Q3 | $567K | Sell |
|
|||||
|
2013
Q2 | $399K | Buy |
|